Your browser doesn't support javascript.
loading
Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany.
Otto-Knapp, Ralf; Häcker, Brit; Krieger, David; Stete, Katarina; Starzacher, Katharina; Maier, Christina; Heyckendorf, Jan; Avsar, Korkut; Suárez, Isabelle; Rybniker, Jan; Bauer, Torsten; Günther, Gunar; Lange, Christoph.
  • Otto-Knapp R; German Central Committee against Tuberculosis (DZK), Berlin, Germany info@dzk-tuberkulose.de.
  • Häcker B; German Central Committee against Tuberculosis (DZK), Berlin, Germany.
  • Krieger D; Lung Hospital Heckeshorn, Helios Klinikum Emil von Behring, Berlin, Germany.
  • Stete K; Lung Hospital Heckeshorn, Helios Klinikum Emil von Behring, Berlin, Germany.
  • Starzacher K; Division of Infectious Diseases, Department of Medicine II, Medical Center, University of Freiburg, Freiburg, Germany.
  • Maier C; German Central Committee against Tuberculosis (DZK), Berlin, Germany.
  • Heyckendorf J; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
  • Avsar K; German Center for Infection Research (DZIF), TTU-TB, Borstel, Germany.
  • Suárez I; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Rybniker J; Asklepios Fachklinik Gauting, Gauting, Germany.
  • Bauer T; Lungenärzte am Rundfunkplatz, Munich, Germany.
  • Günther G; Department I of Internal Medicine, Faculty of Medicine and University of Cologne, University of Cologne, Cologne, Germany.
  • Lange C; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University of Cologne, University of Cologne, Cologne, Germany.
Eur Respir J ; 60(5)2022 11.
Article en En | MEDLINE | ID: mdl-36423919

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Resistente a Múltiples Medicamentos Límite: Humans País como asunto: Europa Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Resistente a Múltiples Medicamentos Límite: Humans País como asunto: Europa Idioma: En Año: 2022 Tipo del documento: Article